FULGENT GENETICS, INC. Other Non-Current Assets
FULGENT GENETICS, INC. (FLGT) had Other Non-Current Assets of $23.95 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-07-30
- 2026-06-30: Other Assets, Noncurrent $23.95M.
- 2026-03-31: Other Assets, Noncurrent $24.98M.
- 2025-12-31: Other Assets, Noncurrent $22.86M.
- 2025-09-30: Other Assets, Noncurrent $23.21M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $23.95M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $24.98M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $22.86M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $23.21M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $23.30M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $32.71M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $33.46M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $39.01M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $32.14M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $32.68M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $34.90M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $38.13M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $49.06M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $45.33M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $44.12M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $61.02M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $61.78M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $34.81M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $10.65M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $8.95M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $8.90M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $5.33M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $4.14M 10-K · filed 2022-02-28 | $3.32M 10-K · filed 2021-03-08 |
| 2020-09-30 | $975.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $80.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $160.00K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $251.00K 10-K · filed 2021-03-08 | |
| 2019-09-30 | $409.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $167.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $231.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $17.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $18.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $20.00K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $30.00K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $39.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $71.00K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $61.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $69.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $17.00K 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |